We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$95.5B
1-Year Est. Return
28.4%
This Fund
S&P 500
This Quarter
Est. Return
-4.17%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$68.3B
AUM Growth
-$3.23B
(-4.5%)
Cap. Flow
-$145M
Cap. Flow
% of AUM
-0.21%
Top 10 Holdings %
Top 10 Hldgs %
15.18%
Holding
779
New
72
Increased
344
Reduced
301
Closed
59
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$374M |
| 2 |
FirstEnergy
FE
|
+$348M |
| 3 |
Allstate
ALL
|
+$267M |
| 4 |
Sanofi
SNY
|
+$259M |
| 5 |
JPMorgan Chase
JPM
|
+$256M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$603M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$561M |
| 3 |
Novartis
NVS
|
+$233M |
| 4 |
KLA
KLAC
|
+$233M |
| 5 |
UnitedHealth
UNH
|
+$207M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.86% |
| 2 | Healthcare | 17.72% |
| 3 | Industrials | 14.6% |
| 4 | Technology | 13.23% |
| 5 | Energy | 10.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Ardmore Shipping
ASC
$669M
| $1.13M | ﹤0.01% |
123,980
-43,449
| -26% | -$387K |
|
502
KB Financial Group
KB
$41.5B
| $1.13M | ﹤0.01% |
37,426
+1,226
| +3% | +$44.3K |
|
503
Willis Towers Watson
WTW
$28.6B
| $1.12M | ﹤0.01% |
+5,553
| New | +$1.15M |
|
504
Western Alliance Bancorporation
WAL
$9.04B
| $1.11M | ﹤0.01% |
16,953
+152
| +0.9% | +$11.5K |
|
505
Lifecore Biomedical
LFCR
$163M
| $1.11M | ﹤0.01% |
124,945
+15,832
| +15% | +$161K |
|
|
SOVO
506
DELISTED
Sovos Brands, Inc. Common Stock
SOVO
| $1.09M | ﹤0.01% |
76,877
+7,830
| +11% | +$114K |
|
507
Morgan Stanley
MS
$337B
| $1.07M | ﹤0.01% |
13,568
+271
| +2% | +$22.8K |
|
508
Old Second Bancorp
OSBC
$1.27B
| $1.06M | ﹤0.01% |
81,223
-73
| -0.1% | -$1.02K |
|
509
DHT Holdings
DHT
$2.95B
| $1.06M | ﹤0.01% |
140,043
-2,864
| -2% | -$21.5K |
|
510
Perdoceo Education
PRDO
$1.99B
| $1.05M | ﹤0.01% |
102,404
+2,051
| +2% | +$24.5K |
|
|
SJI
511
DELISTED
South Jersey Industries, Inc.
SJI
| $1.04M | ﹤0.01% |
31,247
-967
| -3% | -$33K |
|
512
Innoviva
INVA
$1.57B
| $1.04M | ﹤0.01% |
89,604
+15,612
| +21% | +$214K |
|
513
Genpact
G
$5.45B
| $1.01M | ﹤0.01% |
23,007
+382
| +2% | +$17.6K |
|
514
First Interstate BancSystem
FIBK
$3.67B
| $993K | ﹤0.01% |
24,603
-763
| -3% | -$30.7K |
|
515
International Money Express
IMXI
$386M
| $991K | ﹤0.01% |
43,492
+478
| +1% | +$11.2K |
|
516
Teekay Tankers
TNK
$2.63B
| $983K | ﹤0.01% |
35,710
-8,739
| -20% | -$207K |
|
|
TPC
517
Tutor Perini Cor
TPC
$4.51B
| $983K | ﹤0.01% |
178,017
-4,009
| -2% | -$30.4K |
|
518
AdaptHealth
AHCO
$1.49B
| $977K | ﹤0.01% |
52,037
+1,035
| +2% | +$21.3K |
|
519
Virtu Financial
VIRT
$5.12B
| $972K | ﹤0.01% |
46,802
+8,038
| +21% | +$184K |
|
|
PINE
520
Alpine Income Property Trust
PINE
$341M
| $969K | ﹤0.01% |
59,767
+657
| +1% | +$11.8K |
|
|
PLYM
521
DELISTED
Plymouth Industrial REIT
PLYM
| $967K | ﹤0.01% |
57,553
+633
| +1% | +$12.3K |
|
522
Foster
FSTR
$443M
| $959K | ﹤0.01% |
98,253
-124,631
| -56% | -$1.63M |
|
523
Stellantis
STLA
$16.5B
| $954K | ﹤0.01% |
80,593
+17,094
| +27% | +$230K |
|
|
LUCK
524
Lucky Strike Entertainment
LUCK
$963M
| $949K | ﹤0.01% |
77,120
-64,100
| -45% | -$765K |
|
525
PCB Bancorp
PCB
$398M
| $944K | ﹤0.01% |
52,251
+497
| +1% | +$9.45K |
|
Similar funds
Boston Partners's Q3 2022 Portfolio in Review
As of Q3 2022, Boston Partners held 779 positions worth $68.3B, down 4.5% from $71.6B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Boston Partners's Q3 2022 filing shows 72 new, 344 increased, 301 reduced and 59 closed positions. Its largest new stake was FirstEnergy: 8,800,892 shares worth $326M. The largest sale was Procter & Gamble, an estimated $603M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.
- Boston Partners's largest Q3 2022 buy was FirstEnergy: 8,800,892 shares worth $326M.
- Boston Partners added most to Bristol-Myers Squibb in Q3 2022, an estimated $374M increase.
- Boston Partners's biggest Q3 2022 reduction was Alphabet (Google) Class A, cutting an estimated $561M.
- Boston Partners fully exited Procter & Gamble in Q3 2022, selling an estimated $603M.
- Boston Partners's ten largest holdings make up 15% of its $68.3B portfolio in Q3 2022.
- Boston Partners opened 72 new positions and closed 59 in Q3 2022.
- Boston Partners's portfolio value fell 4.5% quarter-over-quarter to $68.3B.
Based on Boston Partners's 13F filing for Q3 2022, filed 9 Nov 2022.